Principles of Transparency and Best Practice in Scholarly Publishing
Posted on August 3, 2024
Our journal adheres to the Principles of Transparency and Best Practice in Scholarly Publishing (version 4, published on September 15, 2022; https://doaj.org/apply/transparency) developed by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME). The journal’s compliance with this joint statement is outlined in the following checklist.
| JOURNAL CONTENT |
JOURNAL PRACTICES |
ORGANISATION |
BUSINESS PRACTICES |
|
|
|
|
JOURNAL CONTENT
1. Name of journal
The official journal title is Diabetes & Metabolism Journal (abbreviated as Diabetes Metab J or dmj).
2. Website
The official website of the journal is https://e-dmj.org. The Diabetes & Metabolism Journal team is dedicated to maintaining a high-quality site that provides accurate information while upholding ethical and professional standards. The site contains no misleading content, and there are no attempts to imitate other journal or publisher websites. Detailed information for authors and readers is easily accessible. Key sections can be found by clicking on the following headings.
3. Publishing schedule
The Diabetes & Metabolism Journal is published bimonthly on the first day of January, March, May, July, September, and November. Supplementary or special issues may also be published as needed.
4. Archiving
The full text of articles from the Diabetes & Metabolism Journal has been archived in PubMed Central (https://www.ncbi.nlm.nih.gov/pmc/journals/1508) since 2010 (starting from volume 34), the Korea Citation Index (https://www.kci.go.kr), and the National Library of Korea (https://nl.go.kr). The journal ensures the long-term availability of its contents, even if the journal ceases publication, through these archiving platforms.
5. Copyright
The copyright, including the rights of online transmission, is owned by the Korean Diabetes Association. All authors are required to sign and submit a copyright transfer agreement during the submission process. Copyright information is provided on all published papers (in both HTML and PDF formats) as well as on the Diabetes & Metabolism Journal website.
6. Licensing
The Diabetes & Metabolism Journal is an open-access journal distributed under the terms of the Creative Commons License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Permission from the journal’s publisher is not required to reuse tables or figures for scholarly or educational purposes in other journals, books, or media. All journal content is made freely available immediately upon publication, with no embargo period. Licensing information is clearly indicated on all published articles (in both HTML and PDF) and on the journal website.
JOURNAL PRACTICES
7. Publication ethics and related editorial policies
The Diabetes & Metabolism Journal adheres to the guidelines and best practices set by professional organizations, including the ICMJE Recommendations, the Committee on Publication Ethics (COPE) Guidelines (https://publicationethics.org/resources/guidelines), and the Good Publication Practice Guideline for Medical Journals (https://www.kamje.or.kr/board/view?b_name=bo_publication&bo_id=13). Additionally, all procedures for addressing research and publication misconduct will follow the applicable COPE flowcharts (https://publicationethics.org/guidance/Flowcharts). Instances of misconduct will be reported to the editorial board, and the editor may impose sanctions, notify editors of other biomedical journals, or, depending on the severity, inform the author’s institution.
8. Peer review
The Diabetes & Metabolism Journal uses an online submission and peer review system (https://www.editorialmanager.com/dmj/). Detail information about the peer review can be found in the Peer Review Policy section on the Editorial and Review Policy page. The key aspects of our policy is as follows:
All submissions, including invited manuscripts, undergo peer review. The Diabetes & Metabolism Journal follows a double-blind peer review process, meaning the identities of both the authors and reviewers kept confidential. However, the decision-making editors has access to the identities of both parties throughout the review process. Reviewers are selected by the editorial board based on their expertise, publication history, and prior review performance.
During the peer review process, reviewers communicate only with the editor through the submission system or via email. This approach is known as “independent review.” Typically, an initial decision is made within two weeks after reviewers agree to evaluate a manuscript. Information regarding the review process or editorial decision process is not made publicly available on the article page.
Manuscripts submitted by editors, employees, or members of the editorial board are treated the same as unsolicited submissions. Authors, including editors, do not participate in the selection of reviewers or in the decision-making process for their own manuscripts. In cases where editors submit their own work, they are not involved in handling the review process, even if the manuscript was solicited.
All articles in the Diabetes & Metabolism Journal include the submission, revision, acceptance, and publication dates on their respective article page.
9. Access
The Diabetes & Metabolism Journal is freely accessible on its official website (https://e-dmj.org) under a the Creative Commons License (https://creativecommons.org/licenses/by/4.0/). Full-text articles are available for free in both XML and PDF formats immediately upon publication with no embargo period.
ORGANISATION
10. Ownership and management
The Diabetes & Metabolism Journal is owned by its publisher, the Korean Diabetes Association (http://www.diabetes.or.kr). The full names and affiliations of the journal management team can be found on the About section (Management team tab) of the journal’s homepage.
11. Advisory body
The Diabetes & Metabolism Journal’s advisory board is its editorial board. The names and affiliations of all editorial board members are listed on the journal’s homepage under the Editorial board tab, with detailed information accessed through links to their ORCID and Scopus Author Profiles.
12. Editorial Team and Contact Information
The editorial team responsible for managing and publishing the journal's content is listed under the About section (Management team tab) on the journal homepage. Contact information for the Editor-in-Chief and the editorial office can be found under the About section (Contact us tab).
BUSINESS PRACTICES
13. Author fees
An article processing charge (APC) is required for all articles accepted for publication in the Diabetes & Metabolism Journal. The standard APC is USD 1,000 for original articles, uninvited reviews, and brief reports. For industry-sponsored articles, the APC is USD 3,000. Invited reviews, editorials, and letters to the editor are exempt from APCs. Payment must be completed prior to publication. The editorial process will proceed only after the payment method has been confirmed.
The following table outlines the applicable fees by article type.
| Article Type |
APC (USD) |
Industry-Sponsored APC (USD) |
| Original Articles |
1,000 |
3,000 |
| Uninvited Reviews |
1,000 |
3,000 |
| Brief Reports |
1,000 |
3,000 |
| Invited Reviews |
No charge |
No charge |
| Editorials |
No charge |
No charge |
| Letters to the Editor |
No charge |
No charge |
The Diabetes & Metabolism Journal offers waivers or discounts to authors from countries classified as low-income by the World Bank (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519/) as of July in the year preceding submission. Authors requesting a waiver must contact the editorial office (diabetes@kams.or.kr) at the time of submission. To ensure editorial impartiality, editors are not informed when a waiver is granted.
14. Other revenue
The journal’s revenue is generated from the support of its publisher, Korean Diabetes Association, as well as from advertising fees.
15. Advertising
This academic journal adheres to the Korean Research-based Pharmaceutical Industry Association (KRPIA) Fair Competition Code and Working Guideline regarding advertising and pricing. For more details, please refer to: https://www.krpia.or.kr/board/lists/fairRule. Organizations or individuals interested in advertising their products or services are invited to contact the editorial office. All advertisements are subject to review by the editorial board and final approval by the publisher.
16. Direct marketing
The Diabetes & Metabolism Journal promotes itself through its website and by distributing an introduction pamphlet. Manuscript submission invitations are typically extended to presenters at conferences, seminars, or workshops that align with the journal's aims and scope.
Additionally, we affirm our commitment to the principles of accessibility, diversity, equity, and inclusivity in all aspects of publication. Editorial decisions are based solely on scholarly merit and not influenced by the authors' nationality, race, ethnicity, region, or political beliefs. The journal is dedicated to ensuring that its policies foster an inclusionary environment and will regularly review them to maintain this commitment.
KDA
